Patients with grade 4 cholangiocarcinoma exhibited significantly poorer OS than patients with grade 1–3 cholangiocarcinoma (p = 0.017, Fig. 4E) and similar OS compared to patients with annexin A10 positive cholangiocarcinoma (p = 0.209, Fig. 4F). This evidence concerns the gene ANXA10 and cholangiocarcinoma.